Patent · US Active

Probiotic bifidobacterium strain

US10597739B2 · kind B2 · utility

0Cited by
1References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 27, 2018
Grant dateMar 24, 2020
Priority date
Expiry dateMar 27, 2038

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.